Centurium Capital
Centurium Capital is a China-focused private equity firm founded in 2017 by David Li, managing over US$7 billion in AUM across healthcare, technology, consumer, and business services sectors. The firm pursues control and significant minority investments with hands-on operational engagement, holding controlling stakes in Luckin Coffee, ANE Logistics, and Taibang Biologic.
- Company typePrivate
- Founded2017
- HeadquartersBeijing, China
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Centurium Capital does
Centurium Capital is a China-focused private equity firm founded in 2017 by David Li, who serves as Chairman and CEO. The firm is legally domiciled in Hong Kong S.A.R. (as Centurium Capital Management Ltd.) and operates from headquarters in Xiamen with regional offices in Beijing, Shanghai, and Hong Kong. It pursues control or significant minority investments in mid-to-large Chinese companies across four verticals: healthcare, hard technology, consumer, and business services, executing an "invest to transform" strategy that combines capital with hands-on operational engagement to address structural deficiencies and improve efficiency. As of December 31, 2023, Centurium managed over US$7 billion in assets under management across both USD and RMB funds, with a portfolio of 30+ companies and a lean 51-100 employee headcount. The LP base comprises global institutional investors including pension funds, sovereign wealth funds, family offices, corporate pensions, and funds of funds.
Revenue is generated through two standard PE mechanisms: management fees on committed and invested capital across its fund vintages, and carried interest (performance fees) on successful portfolio company exits and realizations. The firm distributes capital directly through equity investments rather than traditional sales channels, and markets itself to institutional LPs through industry awards, ESG reporting (PRI signatory since 2022), and portfolio-company referrals. The firm has built meaningful concentrations in select verticals: a controlling stake in Luckin Coffee (23.28% equity, 44% voting power) makes it the dominant coffee retail investor, with recent acquisitions of Ruhlamat (industrial automation) and Blue Bottle Coffee (Nestlé cafe operations) extending the operational footprint into manufacturing equipment and overseas consumer markets. Major historical exits include the take-private of Nasdaq-listed China Biologic Products (Taibang Biologic Group, April 2021) and the privatization of Hong Kong-listed ANE Logistics (February 2026).
Centurium Capital firmographics
Firmographics- Name
- Centurium Capital
- Legal name
- Centurium Capital Management Ltd.
- Website
- https://centurium.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Centurium Capital is a China-focused private equity firm founded in 2017 by David Li, managing over US$7 billion in AUM across healthcare, technology, consumer, and business services sectors. The firm pursues control and significant minority investments with hands-on operational engagement, holding controlling stakes in Luckin Coffee, ANE Logistics, and Taibang Biologic.
- Ownership category
- akta.pro rank
Centurium Capital industry classification
Industry- Product category
- Private Equity Investment Management
- NAICS
- Other Investment Pools and Funds (5259)
- akta.pro primary industry
- Turnaround / Restructuring Private Equity Funds (FSANAKAC)
Keywords
Where Centurium Capital is headquartered
LocationHeadquarters
- HQ city
- Beijing
- HQ country
- China
- HQ region
- Asia
Offices4 records
Markets served
Centurium Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Fund Management: Centurium Capital generates revenue through management fees on its managed assets under management (AUM), and carried interest (performance fees) from successful portfolio company exits and realizations.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Centurium Capital product offering
Product offeringCore offering
Centurium Capital is a China-focused private equity investment firm that raises and manages USD and RMB funds to make control and significant minority equity investments in Chinese companies across healthcare, technology, consumer, and business services sectors. The firm pursues an 'invest to transform' strategy, providing long-term capital combined with hands-on operational engagement to drive efficiency improvements and resolve structural deficiencies in portfolio companies. Revenue is generated through management fees on assets under management and carried interest from successful exits.
Product overview
Centurium Capital is a leading China-focused private equity investment firm that does not offer a unified software product but rather manages private equity investment funds. The firm's core offering is its investment management services targeting healthcare, hard technology, consumer, and business services sectors in China. Key portfolio companies include Luckin Coffee (coffee retail chain), Ruhlamat (industrial automation), Seyond (LiDAR technology), Innogen (biotech/GLP-1 drugs), Sinotau (radiopharmaceuticals), Fadada (e-signature services), ANE Logistics (LTL trucking), Taibang Biologic (plasma biopharma), and UIB Healthcare (children's hospitals).
Differentiator
Problem solved
Functional benefit
Products and services
- Centurium Capital Investment Funds (USD and RMB)
- Luckin Coffee (瑞幸咖啡)
- Luckin Instant Coffee Bottled Ready-to-Drink Coffee (瑞幸即享瓶装咖啡)
- ANE Logistics (安能物流)
- Taibang Biologic Group (泰邦生物集团)
- Ruhlamat Group (儒拉玛特)
- Blue Bottle Coffee (café operations)
- Fadada (法大大)
Companies that use Centurium Capital
Customer profileSegments3 records
Ideal customer profiles2 records
Centurium Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Centurium Capital partnerships and signals
Strategic signalScale indicators5 records
Recent moves10 records
Expansion highlights6 records
Centurium Capital competitors and assessment
Company assessmentDirect peers
- FountainVest Partners: China-focused PE firm investing in control and growth equity across consumer, healthcare and industrials — highly comparable fund size, sector mix, and control-investment approach to Centurium.
- Hillhouse Capital: Asia-focused investment platform with large AUM deploying growth and control capital across China consumer, healthcare and tech — directly comparable strategy and sector mix to Centurium, though at meaningfully greater scale.
- Boyu Capital: China-focused private equity firm taking control and significant minority stakes in consumer, healthcare and tech — closely comparable control-oriented China PE strategy and target sectors to Centurium.
- CITIC Capital: Hong Kong/China alternative asset manager with PE, special situations and real-asset strategies — co-led the China Biologic privatization with Centurium and shares the control/minority China PE playbook.
- HongShan (formerly Sequoia China): Leading China venture/growth platform covering consumer, tech and healthcare — directly comparable China-centric sector coverage and LP profile, though at much larger AUM scale.
- PAG (Pacific Alliance Group): Asia-focused alternative investment firm with PE, real estate and credit strategies — comparable control-investment orientation across Asia/China and similar mid-to-large cap deal size.
- Hopu Investments: China-focused PE manager with control/minority stakes across consumer, financial services and industrials — directly comparable China control-PE strategy and target sectors.
- CDH Investments: Long-standing China-focused PE firm with consumer/healthcare/industrials exposure — directly comparable China PE strategy, though at greater scale and with deeper historical exit track record.
Broad incumbents
- KKR (Asia/China): Global alternative asset manager with substantial Asia/China PE activity — overlaps with Centurium on large-cap China control deals but operates much broader geographic and strategy mandates.
- Carlyle Group (Asia/China): Global PE firm with active Asia and China investment programs — competes with Centurium for control deals in China consumer and industrials but as part of a much larger global portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Centurium Capital compliance and trust
Trust signalCompliance2 records
Centurium Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Centurium Capital leadership team
Management profileNumber of profiles
Profiles9 records
Centurium Capital subsidiaries and ownership
Company hierarchySubsidiaries4 records
Centurium Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Centurium Capital M&A and investment
M&A and investmentM&A5 records
Investments36 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Centurium Capital
What does Centurium Capital do?
Centurium Capital is a China-focused private equity investment firm that raises and manages USD and RMB funds to make control and significant minority equity investments in Chinese companies across healthcare, technology, consumer, and business services sectors. The firm pursues an 'invest to transform' strategy, providing long-term capital combined with hands-on operational engagement to drive efficiency improvements and resolve structural deficiencies in portfolio companies. Revenue is generated through management fees on assets under management and carried interest from successful exits.
Is Centurium Capital a public or private company?
Centurium Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Centurium Capital founded?
Centurium Capital was founded in 2017. It employs 51 to 100 people.
Where is Centurium Capital based?
Centurium Capital is headquartered in Beijing, China, in the Asia region.
How does Centurium Capital make money?
One revenue line is on record: fund Management.
Who are Centurium Capital's main competitors?
Direct peers on record are FountainVest Partners, Hillhouse Capital, Boyu Capital, CITIC Capital, HongShan (formerly Sequoia China), PAG (Pacific Alliance Group), Hopu Investments and CDH Investments. Broad incumbents are KKR (Asia/China) and Carlyle Group (Asia/China).
Does Centurium Capital have an API?
No public API is recorded for Centurium Capital.
What industry is Centurium Capital in?
Centurium Capital's product category is Private Equity Investment Management. Its primary akta.pro industry code is FSANAKAC, Turnaround / Restructuring Private Equity Funds. Its NAICS code is 5259.